The relationship between stroma AReactive invasion front areas (SARIFA), warburg-subtype and survival: results from a large prospective series of colorectal cancer patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancer & Metabolism, 12, 1, S. 21-
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2024
- Event
-
Veröffentlichung
- (who)
-
Springer Science and Business Media LLC
- (when)
-
2024
- Creator
-
Offermans, Kelly
Reitsam, Nic G.
Simons, Colinda C. J. M.
Grosser, Bianca
Zimmermann, Jessica
Grabsch, Heike I.
Märkl, Bruno
van den Brandt, Piet A.
- DOI
-
10.1186/s40170-024-00349-z
- URN
-
urn:nbn:de:bvb:384-opus4-1142646
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Offermans, Kelly
- Reitsam, Nic G.
- Simons, Colinda C. J. M.
- Grosser, Bianca
- Zimmermann, Jessica
- Grabsch, Heike I.
- Märkl, Bruno
- van den Brandt, Piet A.
- Universität Augsburg
- Springer Science and Business Media LLC
Time of origin
- 2024
Other Objects (12)
Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor
Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion
Alterations in natural killer cells in colorectal cancer patients with Stroma AReactive Invasion Front Areas (SARIFA)
Die Bedeutung der Expression der eukaryotischen Initiationsfaktoren in Speicheldrüsentumoren - eine immunhistochemische, retrospektive Studie
Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor
Immunhistochemische Untersuchung der eukaryotischen Initiationsfaktoren 4-6 in Neoplasien des Ovars
The concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial
Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor‐promoting adipocytes
Artificial intelligence in colorectal cancer: from patient screening over tailoring treatment decisions to identification of novel biomarkers
Can low autopsy rates be increased? Yes, we can! Should postmortem examinations in oncology be performed? Yes, we should! A postmortem analysis of oncological cases
The impact of progredient vessel and tissue stiffening for the development of metabolic syndrome
Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor
Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion
Alterations in natural killer cells in colorectal cancer patients with Stroma AReactive Invasion Front Areas (SARIFA)
Die Bedeutung der Expression der eukaryotischen Initiationsfaktoren in Speicheldrüsentumoren - eine immunhistochemische, retrospektive Studie
Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor
Immunhistochemische Untersuchung der eukaryotischen Initiationsfaktoren 4-6 in Neoplasien des Ovars
The concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial
Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor‐promoting adipocytes
Artificial intelligence in colorectal cancer: from patient screening over tailoring treatment decisions to identification of novel biomarkers
Can low autopsy rates be increased? Yes, we can! Should postmortem examinations in oncology be performed? Yes, we should! A postmortem analysis of oncological cases
The impact of progredient vessel and tissue stiffening for the development of metabolic syndrome
Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor
Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion
Alterations in natural killer cells in colorectal cancer patients with Stroma AReactive Invasion Front Areas (SARIFA)
Die Bedeutung der Expression der eukaryotischen Initiationsfaktoren in Speicheldrüsentumoren - eine immunhistochemische, retrospektive Studie
Inflammatory angiomyolipoma of the liver: an unusual case suggesting relationship to IgG4-related pseudotumor
Immunhistochemische Untersuchung der eukaryotischen Initiationsfaktoren 4-6 in Neoplasien des Ovars
The concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial
Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor‐promoting adipocytes
Artificial intelligence in colorectal cancer: from patient screening over tailoring treatment decisions to identification of novel biomarkers
Can low autopsy rates be increased? Yes, we can! Should postmortem examinations in oncology be performed? Yes, we should! A postmortem analysis of oncological cases